Carlyle forms healthcare platform Atmas Health; Florida SBA’s ESG ban and its impact commitments

Carlyle teams up with three healthcare execs to launch new healthcare platform.


Hope things are moving along well now that we’re all back from the long, hot summer.

Healthcare: Carlyle Group is announcing this morning the formation of Atmas Health, an acquisition platform for assets in med-tech and products, life sciences tools and diagnostics sectors.Atmas will be financed by Carlyle as well as investments from three healthcare executives it’s working with on the formation of the platform, Kieran Gallahue, Jim Hinrichs and Jim Prutow. Atmas Health will pursue various types of transactions, including buy-and-builds and carve-outs and will look at founder-led businesses as well as take-privates, Gallahue said in a statement.

Gallahue is the former chairman and CEO of CareFusion from 2011 until its sale to Becton, Dickinson and Co. for more than $12 billion in 2015. Hinrichs is former CFO of Alere from 2015 until its sale to Abbott for $8 billion in 2017, and former CFO of CareFusion from 2010 to 2015. Prutow is a former partner at PwC, specializing in M&A diligence.

Read more here on PE Hub.

Florida man: Florida recently barred its pensions system from considering ESG factors when making investments, which would seem to include private equity commitments (though pension spokespeople aren’t clarifying for us).
So a big question is what will happen with the system’s existing holdings in two of the largest-ever impact funds, TPG’s Rise Funds I and II. Florida is a backer of both funds, having committed $25 million to the first Rise Fund and $50 million to the second, according to pension documents.

The first Rise Fund, which closed on $2 billion in 2017, was generating a 19 percent IRR and a 1.6x multiple as of June 30, according to TPG’s second quarter earnings report. Fund II, which raised at least $2.17 billion as of 2020, was producing a 26 percent IRR and a 1.2x multiple as of the same date, TPG reported.

The question is, whether Florida’s new pension rules, instituted last month, will grandfather in PE investments with an ESG flavor, or whether the system will need to sell them on the secondaries market. I’m also curious how the new ESG ban will interact with the system’s investments in emerging managers, which often include firms led by women and minorities. Diversity is considered one of the pillars of ESG strategy. Read more here on Buyouts.

New job: Big news for a guru of private equity: David Fann, who formed and led TorreyCove Capital Partners for many years, has joined Apogem Capital as vice chairman and senior managing director focused on business development and investor relations.

Apogem formed earlier this year from the combination of PA Capital, Madison Capital Funding and GoldPoint Partners. It managed about $39 billion as of March 30 and targets a range of strategies, including direct lending, junior debt, primary fund commitments, secondaries, co-investments and GP stakes. Read more here on PE Hub.

That’s it for me! Have a great rest of the day. Hit me up with tips n’ gossip or good Drama at or over on LinkedIn.